Yoshikazu Mutoh

A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19

Yohei Doi, Masaya Hibino, Ryota Hase et al. · Antimicrobial Agents and Chemotherapy · 2020 · 231 citations · Full text

Open-label Trial, Late Favipiravir Therapy, Clinical Infectious Disease +14

Clinical Characteristics of Patients with Coronavirus Disease (COVID-19): Preliminary Baseline Report of Japan COVID-19 Task Force, a Nationwide Consortium to Investigate Host Genetics of COVID-19

Hiromu Tanaka, Ho Lee, Atsuho Morita et al. · International Journal of Infectious Diseases · 2021 · 58 citations · Full text

Characteristics of hospitalized patients with COVID-19 during the first to fifth waves of infection: a report from the Japan COVID-19 Task Force

Ho Lee, Shotaro Chubachi, Ho Namkoong et al. · BMC Infectious Diseases · 2022 · 50 citations · Full text

The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force

Qingbo S. Wang, Ryuya Edahiro, Ho Namkoong et al. · Nature Communications · 2022 · 48 citations · Full text

Impact of upper and lower respiratory symptoms on COVID-19 outcomes: a multicenter retrospective cohort study

Kensuke Nakagawara, Shotaro Chubachi, Ho Namkoong et al. · Respiratory Research · 2022 · 28 citations · Full text